Literature DB >> 24061695

Epidemiology of patients hospitalised for pneumonia in 2011: a prospective multicentre cohort study.

Christoph Wenisch1, Günter Weiss, Arno Lechner, Michael Meilinger, Karl Rittler, Nina Muzatko, Beate Pomogyi, Mathilde Kutilek, Rosa Bellmann-Weiler, Ursula-Maria Fürst, Alexander Andorfer, Judith Maria Wenisch.   

Abstract

This study was conducted to investigate the age dependent epidemiology of pneumonia and risk factors for mortality.The data were derived from the Austrian Pneumonia Network (APNET), comprising nine Departments for Internal Medicine with a total of 1,011 hospital beds. All inpatients diagnosed with pneumonia during 2011 were followed until discharge. Identification of microorganisms was performed according to local standard methods. Data of patients < 65 years and ≥ 65 years were compared by Mann-Whitney and the Chi-square tests. Risk factors for hospital mortality were evaluated by univariate and multivariate analyses.Overall, 1,956 patients were included. The hospital mortality was 10.4 %, and was higher in patients ≥ 65 (12.7 %) than in patients < 65 years of age (5.0 %; p < 0.001). Streptococcus (S.) pneumoniae was the most important pathogen. Enterobacteriacaeae were revealed significantly more often in patients ≥ 65 years. Age ≥ 65 years, chronic heart failure (CHF) and neurological disease increased the risk of hospital mortality 1.96 (95 % CI 1.19-3.20), 1.59 (95 % CI 1.10-2.29), and 1.7 (95 % CI 1.19-2.41)-fold, respectively.In conclusion, pneumonia patients with CHF, neurological disease and age ≥ 65 years could benefit from intensified care due to increased risk of in-hospital death.

Entities:  

Mesh:

Year:  2013        PMID: 24061695     DOI: 10.1007/s00508-013-0419-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  31 in total

Review 1.  Ageing and infection.

Authors:  Gaëtan Gavazzi; Karl-Heinz Krause
Journal:  Lancet Infect Dis       Date:  2002-11       Impact factor: 25.071

2.  Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

Authors:  Vicente F Corrales-Medina; Daniel M Musher; George A Wells; Julio A Chirinos; Li Chen; Michael J Fine
Journal:  Circulation       Date:  2012-01-04       Impact factor: 29.690

3.  The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia.

Authors:  E Barrett-Connor
Journal:  Am Rev Respir Dis       Date:  1971-06

4.  [Fever in the elderly patient].

Authors:  H J Heppner; C Sieber; W Mühlberg; A S Esslinger
Journal:  MMW Fortschr Med       Date:  2006-01-26

5.  Epidemiology of community-acquired pneumonia in Edmonton, Alberta: an emergency department-based study.

Authors:  Thomas J Marrie; Jane Q Huang
Journal:  Can Respir J       Date:  2005-04       Impact factor: 2.409

6.  A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.

Authors:  Marcos I Restrepo; Eric M Mortensen; Jose A Velez; Christopher Frei; Antonio Anzueto
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

7.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

8.  Dementia and dysphagia.

Authors:  Caryn S Easterling; Elizabeth Robbins
Journal:  Geriatr Nurs       Date:  2008 Jul-Aug       Impact factor: 2.361

9.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

10.  Roy Walford and the immunologic theory of aging.

Authors:  Rita B Effros
Journal:  Immun Ageing       Date:  2005-04-25       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.